eFFECTOR Therapeutics Receives $14,666,666 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8f547390-bb7b-4542-9cac-335e31f9c2b6
Date
7/27/2015
Company Name
eFFECTOR Therapeutics
Mailing Address
11180 Roselle Street San Diego, CA 92121 USA
Company Description
eFFECTOR Therapeutics is pioneering a new class of small molecule drugs that act by selectively regulating translation, also known as protein synthesis. The company unites breakthrough insights into the mechanisms of translational control with a proven approach to product invention.
Website
http://www.effector.com
Transaction Type
Venture Equity
Transaction Amount
$14,666,666
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing – amended. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor
Undisclosed